Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study

Publication

Lancet Microbe 2025; 6: 101019 ESGMAC MAPS study group Abstract: Background: Mycoplasma pneumoniae is a major cause of respiratory tract infections. We aimed to investigate the spatiotemporal dynamics, antimicrobial resistance, and severity of the delayed re-emergence of infections with M pneumoniae after the implementation of non-pharmaceutical interventions (NPIs) against COVID-19. Methods:Epidemiological data (positive and total…

Read More

Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia

Publication

Emerging Infectious Diseases – 2025, 31, 8.  Nicolas M. Legrand, Rowena A. Bull, Behzad Hajarizadeh, Andrew R. Lloyd, Kirsty Johnston, Katya Issa, Christine Harvey, Alicia Arnott, Dominic E. Dwyer, Vitali Sintchenko, Luke Grant, Gregory J. Dore, John Kaldor, Marianne Martinello Abstract: Limited surveillance data have hindered understanding of SARS-CoV-2 transmission within prisons. We integrated routine…

Read More

Diagnosis of Viral Families Using Nucleic Acid Simplification Technique

resource thumbnail 732x394 feb23

By Dr. Douglas Millar and Dr. John Melki From the edited volume Dengue Fever in a One Health Perspective – Latest Research and Recent Advances published by IntechOpen, January 19th, 2023 Abstract We have developed a novel strategy to simplify microbial nucleic acids termed 3base™. This technology uses the chemical sodium bisulphite to reduce the…

Read More

Validation of Saliva Samples with the EasyScreen™ 3base™ SARS-CoV-2 Detection Kit (RP012)

The need for accurate SARS-CoV-2 testing remains a priority. While nasopharyngeal (NP) swabs and PCR tests are considered the most sensitive and accurate, there is a need for simpler sample collection. Saliva has been investigated as an alternate sample type and validated in this study as a sampling method for SARS-CoV-2 detection. View our poster…

Read More

TechInvest Magazine Chats with John Melki for Their Current Magazine Issue

The article looks at our ongoing growth as an Australian biotech company and how our proprietary 3base technology has allowed us to respond to the COVID-19 pandemic, as well as accelerate global rollout of diagnostics for enterics, sexual health and a pipeline of new products. TechInvest Magazine 

Read More

A novel nucleic acid simplification procedure capable of detecting multiple strains of both DNA and RNA viruses in a single reaction

Publication

N. Boulter, S.P. Siah, N. Coulston, C. Vockler, K. Warton, P. Rajasekariah, J.R. Melki and D.S Millar. A novel nucleic acid simplification procedure capable of detecting multiple strains of both DNA and RNA viruses in a single reaction. 24th Annual Clinical Virology Symposium. Daytona Beach, FL, U.S.A. 27 – 30 April, 2008

Read More

The Application of a Novel DNA Simplification Approach for the Universal Detection and Subtyping of Gram-Positive Bacteria

Publication

D. S. Millar, C. J. Vockler, J. R. Melki. The Application of a Novel DNA Simplification Approach for the Universal Detection and Subtyping of Gram-Positive Bacteria. 107th American Society for Microbiology General Meeting, Toronto, Canada May 21-25, 2007

Read More

Specific detection of Hepatitis C virus in clinical samples using a novel simplification strategy

Publication

N. Boulter, S.P. Siah, N. Coulston, C. Vockler, K. Warton, P. Rajasekariah, J.R. Melki and D.S Millar. Specific detection of Hepatitis C virus in clinical samples using a novel simplification strategy. 18th ECCMID meeting, Barcelona, 19-22 April 2008

Read More